AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 3754433 — intervention group
Group type: COMPARATOR
Intervention: Control group (no brace)
Number of subjects: 17
Study 30711651 — intervention group
Group type: EXPERIMENTAL
Intervention: Accelerated vaccination schedule (0, 7, and 21 days)
Number of subjects: 126
Study 30711651 — intervention group
Group type: COMPARATOR
Intervention: Routine vaccination schedule (0, 1, and 6 months)
Number of subjects: 126
Study 30711651 — intervention group
Group type: EXPERIMENTAL
Intervention: Accelerated vaccination schedule
Number of subjects: 126
Study 30711651 — intervention group
Group type: COMPARATOR
Intervention: Routine vaccination schedule
Number of subjects: 126
Study 28352939 — intervention group
Group type: EXPERIMENTAL
Intervention: Individualized physiotherapy and shoulder taping
Number of subjects: 140
Study 28352939 — intervention group
Group type: COMPARATOR
Intervention: Individualized physiotherapy only
Number of subjects: 140
Study 26537897 — intervention group
Group type: EXPERIMENTAL
Intervention: Extensively hydrolyzed milk protein formula (100% whey protein)
Number of subjects: 370
Study 26537897 — intervention group
Group type: COMPARATOR
Intervention: Preterm children's formula
Number of subjects: 370
Study 23384977 — intervention group
Group type: EXPERIMENTAL
Intervention: Active encouragement for diagnostics and treatment after screening
Number of subjects: 0
Study 23384977 — intervention group
Group type: COMPARATOR
Intervention: Care as usual (control group)
Number of subjects: 0
Study 21340599 — intervention group
Group type: EXPERIMENTAL
Intervention: Children's Yale-Brown Obsessive Compulsive Scale (CY-BOCS) total scale
Number of subjects: 42
Study 21340599 — intervention group
Group type: EXPERIMENTAL
Intervention: Children's Yale-Brown Obsessive Compulsive Scale (CY-BOCS) Obsessions subscale
Number of subjects: 42
Study 21340599 — intervention group
Group type: EXPERIMENTAL
Intervention: Children's Yale-Brown Obsessive Compulsive Scale (CY-BOCS) Compulsions subscale
Number of subjects: 42
Study 19403719 — intervention group
Group type: EXPERIMENTAL
Intervention: Plant stanol drink (2.0 g/d)
Number of subjects: 36
Study 19403719 — intervention group
Group type: EXPERIMENTAL
Intervention: Simvastatin (10 mg)
Number of subjects: 36
Study 19403719 — intervention group
Group type: EXPERIMENTAL
Intervention: Simvastatin + Plant stanol drink
Number of subjects: 36
Study 19403719 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 36
Study 17850382 — intervention group
Group type: EXPERIMENTAL
Intervention: Montelukast 10 mg daily
Number of subjects: 60
Study 17850382 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study 15459610 — intervention group
Group type: EXPERIMENTAL
Intervention: Nicorandil (4 mg as a bolus injection followed by constant infusion at 8 mg/hour for 24 hours)
Number of subjects: 58
Study 15459610 — intervention group
Group type: EXPERIMENTAL
Intervention: Nicorandil
Number of subjects: 58
Study 15459610 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 58
Study 11271456 — intervention group
Group type: EXPERIMENTAL
Intervention: Excimer laser trephination (193‐nm Meditec MEL60)
Number of subjects: 179
Study 11271456 — intervention group
Group type: COMPARATOR
Intervention: Motor trephination with the Mikrokeratron
Number of subjects: 179
Study 9749683 — intervention group
Group type: EXPERIMENTAL
Intervention: TENS (110Hz, 200microsec)
Number of subjects: 50
Study 9749683 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 50
Study 8147334 — intervention group
Group type: EXPERIMENTAL
Intervention: 20 mg beta-carotene (BC) daily for 4 weeks in smokers
Number of subjects: 70
Study 8147334 — intervention group
Group type: COMPARATOR
Intervention: Placebo in smokers
Number of subjects: 70
Study 8147334 — intervention group
Group type: EXPERIMENTAL
Intervention: 20 mg beta-carotene (BC) daily for 4 weeks in nonsmokers
Number of subjects: 70
Study 8147334 — intervention group
Group type: COMPARATOR
Intervention: Placebo in nonsmokers
Number of subjects: 70
Study 3169754 — intervention group
Group type: EXPERIMENTAL
Intervention: Pivampicillin (700 mg twice a day for 7 days)
Number of subjects: 49
Study 3169754 — intervention group
Group type: COMPARATOR
Intervention: Erythromycin (500 mg twice a day for 7 days)
Number of subjects: 49
Study 3169754 — intervention group
Group type: EXPERIMENTAL
Intervention: Pivampicillin
Number of subjects: 49
Study 3169754 — intervention group
Group type: COMPARATOR
Intervention: Erythromycin
Number of subjects: 49
Study 30063168 — intervention group
Group type: EXPERIMENTAL
Intervention: Native whey protein
Number of subjects: 0
Study 30063168 — intervention group
Group type: EXPERIMENTAL
Intervention: Micellar casein
Number of subjects: 0
Study 30063168 — intervention group
Group type: EXPERIMENTAL
Intervention: Whey-casein blend
Number of subjects: 0
Study 28677416 — intervention group
Group type: EXPERIMENTAL
Intervention: Manual closed-loop delivery using SP-MPC algorithm
Number of subjects: 10
Study 28677416 — intervention group
Group type: COMPARATOR
Intervention: Open-loop using sensor-augmented pump therapy (open-loop SAP)
Number of subjects: 10
Study 26305992 — intervention group
Group type: EXPERIMENTAL
Intervention: Multidisciplinary coordinated intervention by advanced practice nurses
Number of subjects: 146
Study 26305992 — intervention group
Group type: COMPARATOR
Intervention: Enhanced usual care
Number of subjects: 146
Study 23374815 — intervention group
Group type: EXPERIMENTAL
Intervention: Thulium laser transurethral enucleation of the prostate (ThuLEP)
Number of subjects: 158
Study 23374815 — intervention group
Group type: COMPARATOR
Intervention: Plasmakinetic bipolar resection of the prostate (PKRP)
Number of subjects: 158
Study 21505541 — intervention group
Group type: EXPERIMENTAL
Intervention: Clear corneal tunnel incision (Group A)
Number of subjects: 60
Study 21505541 — intervention group
Group type: COMPARATOR
Intervention: Sclero-corneal tunnel incision (Group B)
Number of subjects: 60
Study 19471134 — intervention group
Group type: EXPERIMENTAL
Intervention: Comorbid psychiatric disorders (PD)
Number of subjects: 143
Study 17934380 — intervention group
Group type: EXPERIMENTAL
Intervention: Aripiprazole
Number of subjects: 10
Study 15525863 — intervention group
Group type: EXPERIMENTAL
Intervention: Education by pamphlets
Number of subjects: 129
Study 15525863 — intervention group
Group type: EXPERIMENTAL
Intervention: Education by lecture and flash cards
Number of subjects: 129
Study 15525863 — intervention group
Group type: COMPARATOR
Intervention: Control group (not manipulated)
Number of subjects: 129
Study 12644414 — intervention group
Group type: EXPERIMENTAL
Intervention: Lactate in the prime solution
Number of subjects: 20
Study 12644414 — intervention group
Group type: COMPARATOR
Intervention: Lactate free prime solution
Number of subjects: 20
Study 10363944 — intervention group
Group type: EXPERIMENTAL
Intervention: Long SOA (3.5 s)
Number of subjects: 14
Study 10363944 — intervention group
Group type: EXPERIMENTAL
Intervention: Intermediate SSA and SDA manipulations
Number of subjects: 14
Study 7593107 — intervention group
Group type: EXPERIMENTAL
Intervention: Bupivacaine femoral nerve block
Number of subjects: 50
Study 7593107 — intervention group
Group type: COMPARATOR
Intervention: Systemic analgesia alone
Number of subjects: 50
Study 2266221 — intervention group
Group type: EXPERIMENTAL
Intervention: Individually self-administered video-tape modeling treatment (IVM)
Number of subjects: 43
Study 2266221 — intervention group
Group type: EXPERIMENTAL
Intervention: IVM treatment plus therapist consultation (IVMC)
Number of subjects: 43
Study 2266221 — intervention group
Group type: COMPARATOR
Intervention: Waiting-list control group (CON)
Number of subjects: 43
Study 7393376 — intervention group
Group type: EXPERIMENTAL
Intervention: Nondialyzed uremic patients
Number of subjects: 85
Study 7393376 — intervention group
Group type: EXPERIMENTAL
Intervention: Dialyzed uremic patients
Number of subjects: 85
Study 7393376 — intervention group
Group type: COMPARATOR
Intervention: Healthy volunteers and patients with normal renal functions
Number of subjects: 85
Study 7393376 — intervention group
Group type: EXPERIMENTAL
Intervention: Younger uremic patients (under 55 years)
Number of subjects: 85
Study 30636466 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive-behavioral therapy
Number of subjects: 221
Study 30636466 — intervention group
Group type: EXPERIMENTAL
Intervention: Brief panic-focused psychodynamic psychotherapy
Number of subjects: 221
Study 30636466 — intervention group
Group type: EXPERIMENTAL
Intervention: PDSS
Number of subjects: 221
Study 30636466 — intervention group
Group type: EXPERIMENTAL
Intervention: PDSS-SR
Number of subjects: 221
Study 29578592 — intervention group
Group type: EXPERIMENTAL
Intervention: Cancer prevention seminar
Number of subjects: 395
Study 29578592 — intervention group
Group type: COMPARATOR
Intervention: Biospecimen education seminar
Number of subjects: 395
Study 26156073 — intervention group
Group type: EXPERIMENTAL
Intervention: Everolimus (10 mg once daily, titrated based on tolerability)
Number of subjects: 112
Study 24447434 — intervention group
Group type: EXPERIMENTAL
Intervention: Adjuvant tamoxifen (1-3 years)
Number of subjects: 563
Study 24447434 — intervention group
Group type: COMPARATOR
Intervention: No systemic treatment (observation)
Number of subjects: 563
Study 23145755 — intervention group
Group type: EXPERIMENTAL
Intervention: Bupivacaine 15 mg 0.5% (group 1)
Number of subjects: 44
Study 23145755 — intervention group
Group type: COMPARATOR
Intervention: Levobupivacaine 15 mg 0.5% (group 2)
Number of subjects: 44
Study 21146662 — intervention group
Group type: EXPERIMENTAL
Intervention: PPCI with ischemic postconditioning (IPost)
Number of subjects: 118
Study 21146662 — intervention group
Group type: COMPARATOR
Intervention: Conventional PPCI
Number of subjects: 118
Study 17431208 — intervention group
Group type: EXPERIMENTAL
Intervention: Mild intraoperative hypothermia (33 degrees C)
Number of subjects: 185
Study 17431208 — intervention group
Group type: EXPERIMENTAL
Intervention: Normothermic treatment
Number of subjects: 185
Study 17431208 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 185
Study 15530581 — intervention group
Group type: EXPERIMENTAL
Intervention: Website condition (participants received four stage-targeted e-mails over 8 weeks)
Number of subjects: 327
Study 12355569 — intervention group
Group type: EXPERIMENTAL
Intervention: Dynamic cooling device (DCD) with cryogen spurt duration of 20 milliseconds
Number of subjects: 10
Study 12355569 — intervention group
Group type: EXPERIMENTAL
Intervention: Dynamic cooling device (DCD) with longer spurt durations (40, 60, 80, 100 milliseconds)
Number of subjects: 10
Study 12355569 — intervention group
Group type: EXPERIMENTAL
Intervention: Dynamic cooling device (DCD) with spurt durations of 20-60 milliseconds
Number of subjects: 10
Study 12355569 — intervention group
Group type: COMPARATOR
Intervention: Higher fluences without cooling
Number of subjects: 10
Study 10211629 — intervention group
Group type: EXPERIMENTAL
Intervention: Cardiac troponin T (cTnT)
Number of subjects: 49
Study 10211629 — intervention group
Group type: EXPERIMENTAL
Intervention: Cardiac troponin I (cTnI)
Number of subjects: 49
Study 10211629 — intervention group
Group type: EXPERIMENTAL
Intervention: Follow-up over 18 months
Number of subjects: 49
Study 8556024 — intervention group
Group type: EXPERIMENTAL
Intervention: Appetizer condition (ingestion of pudding before Stroop task)
Number of subjects: 51
Study 8556024 — intervention group
Group type: COMPARATOR
Intervention: No-appetizer condition
Number of subjects: 51
Study 8556024 — intervention group
Group type: EXPERIMENTAL
Intervention: Stroop task with food words
Number of subjects: 51
Study 8556024 — intervention group
Group type: EXPERIMENTAL
Intervention: Stroop task with body shape words
Number of subjects: 51
Study 29643159 — intervention group
Group type: EXPERIMENTAL
Intervention: Multivitamin supplements containing 150 µg iodine
Number of subjects: 1275
Study 27183079 — intervention group
Group type: EXPERIMENTAL
Intervention: Platelet-rich fibrin (PRF) used to cover the autogenous palatal bone block
Number of subjects: 12
Study 27183079 — intervention group
Group type: COMPARATOR
Intervention: Control group (only autogenous palatal bone block without PRF)
Number of subjects: 12
Study 25528742 — intervention group
Group type: EXPERIMENTAL
Intervention: Dynamic Axial Fixator (DAF)
Number of subjects: 20
Study 25528742 — intervention group
Group type: COMPARATOR
Intervention: Locked Compression Plate (LCP)
Number of subjects: 20
Study 23746688 — intervention group
Group type: EXPERIMENTAL
Intervention: Protocol A: 80 mL iopromide 370/4 mL/sec = IDR 1.4 gI/sec
Number of subjects: 120
Study 23746688 — intervention group
Group type: EXPERIMENTAL
Intervention: Protocol B: 80 mL iopromide 370 at 3 mL/sec = IDR 1.1 gI/sec
Number of subjects: 120
Study 23746688 — intervention group
Group type: EXPERIMENTAL
Intervention: Protocol C: 98 mL iopromide 300 at 4.9 mL/sec = IDR 1.4 gI/sec
Number of subjects: 120
Study 23746688 — intervention group
Group type: EXPERIMENTAL
Intervention: Protocol D: 98 mL iopromide 300 at 3.7 mL/sec = IDR 1.1 gI/sec
Number of subjects: 120
Study 23746688 — intervention group
Group type: EXPERIMENTAL
Intervention: Protocol A
Number of subjects: 120
Study 23746688 — intervention group
Group type: EXPERIMENTAL
Intervention: Protocols A and B
Number of subjects: 120
Study 21432621 — intervention group
Group type: EXPERIMENTAL
Intervention: Generic tamsulosin sustained-release tablets (Prostam(®))
Number of subjects: 24
Study 19092351 — intervention group
Group type: EXPERIMENTAL
Intervention: 8 mg dexamethasone
Number of subjects: 72
Study 16871060 — intervention group
Group type: EXPERIMENTAL
Intervention: Remifentanil (0-15 ng/ml) and sevoflurane (0-6 vol%)
Number of subjects: 16
Study 16871060 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of 0.75 vol% sevoflurane and 6.2 ng/ml remifentanil
Number of subjects: 16
Study 16871060 — intervention group
Group type: EXPERIMENTAL
Intervention: Remifentanil and sevoflurane
Number of subjects: 16
Study 14680725 — intervention group
Group type: EXPERIMENTAL
Intervention: 40 mg/day quinapril for 8 weeks
Number of subjects: 336
Study 14680725 — intervention group
Group type: COMPARATOR
Intervention: Placebo for 8 weeks
Number of subjects: 336
Study 10870853 — intervention group
Group type: EXPERIMENTAL
Intervention: 60 mcg PGE1 daily given IV in 250 mL saline over a period of 2 hours (21 patients)
Number of subjects: 42
Study 10870853 — intervention group
Group type: COMPARATOR
Intervention: Placebo (250 mL saline, 21 patients)
Number of subjects: 42
Study 9109265 — intervention group
Group type: EXPERIMENTAL
Intervention: PLA/PGA membranes
Number of subjects: 9
Study 9109265 — intervention group
Group type: COMPARATOR
Intervention: e‐PTFE membranes
Number of subjects: 9
Study 8473092 — intervention group
Group type: EXPERIMENTAL
Intervention: New technique (Group I)
Number of subjects: 80
Study 8473092 — intervention group
Group type: EXPERIMENTAL
Intervention: New technique after failures (Group III)
Number of subjects: 80
Study 8473092 — intervention group
Group type: COMPARATOR
Intervention: Traditional technique (Group II)
Number of subjects: 80
Study 8473092 — intervention group
Group type: EXPERIMENTAL
Intervention: New technique reattempted after failures (Group IV)
Number of subjects: 80
Study 3700954 — intervention group
Group type: EXPERIMENTAL
Intervention: Protective sports eyewear (seven different types); specific dosages and durations not mentioned.
Number of subjects: 0
Study 29722837 — intervention group
Group type: EXPERIMENTAL
Intervention: Fortified mother's milk
Number of subjects: 239
Study 29722837 — intervention group
Group type: EXPERIMENTAL
Intervention: Unfortified mother's milk
Number of subjects: 239
Study 29722837 — intervention group
Group type: COMPARATOR
Intervention: Preterm formula
Number of subjects: 239
Study 29722837 — intervention group
Group type: EXPERIMENTAL
Intervention: Early rapid growth (crossing of weight percentiles with >1 SD)
Number of subjects: 239
Study 27993223 — intervention group
Group type: EXPERIMENTAL
Intervention: Therapist-guided internet-based CBT (BiP OCD)
Number of subjects: 67
Study 27993223 — intervention group
Group type: COMPARATOR
Intervention: Waitlist condition
Number of subjects: 67
Study 25038064 — intervention group
Group type: EXPERIMENTAL
Intervention: MIRT Group (two 28-day multidisciplinary intensive rehabilitation treatments at 1-year interval)
Number of subjects: 40
Study 25038064 — intervention group
Group type: COMPARATOR
Intervention: Control Group (only drug)
Number of subjects: 40
Study 24510077 — intervention group
Group type: EXPERIMENTAL
Intervention: Femtosecond laser Femto LDV(TM) Ziemer
Number of subjects: 32
Study 24510077 — intervention group
Group type: COMPARATOR
Intervention: Microkeratome Hansatome (TM) Bausch & Lomb
Number of subjects: 32
Study 20962323 — intervention group
Group type: EXPERIMENTAL
Intervention: t(14;16) positive patients
Number of subjects: 1003
Study 20962323 — intervention group
Group type: COMPARATOR
Intervention: t(14;16) negative patients
Number of subjects: 1003
Study 18497611 — intervention group
Group type: EXPERIMENTAL
Intervention: Epidural analgesia
Number of subjects: 12
Study 18497611 — intervention group
Group type: COMPARATOR
Intervention: Patient-controlled analgesia with intravenous morphine
Number of subjects: 12
Study 17361522 — intervention group
Group type: EXPERIMENTAL
Intervention: Compound Glycyrrhizin Injection (CGI)
Number of subjects: 42
Study 17361522 — intervention group
Group type: COMPARATOR
Intervention: Conventional treatment
Number of subjects: 42
Study 12553391 — intervention group
Group type: EXPERIMENTAL
Intervention: LMA‐ProSeal laryngeal mask airway
Number of subjects: 30
Study 12553391 — intervention group
Group type: COMPARATOR
Intervention: Classic laryngeal mask airway
Number of subjects: 30
Study 11712434 — intervention group
Group type: EXPERIMENTAL
Intervention: Embolization
Number of subjects: 50
Study 8805994 — intervention group
Group type: EXPERIMENTAL
Intervention: Calcitriol, 1 microgram twice daily
Number of subjects: 36
Study 8805994 — intervention group
Group type: EXPERIMENTAL
Intervention: Calcitriol, 0.5 microgram twice daily
Number of subjects: 36
Study 8805994 — intervention group
Group type: COMPARATOR
Intervention: Placebo twice daily
Number of subjects: 36
Study 1621796 — intervention group
Group type: EXPERIMENTAL
Intervention: Materials-based occupation
Number of subjects: 15
Study 1621796 — intervention group
Group type: EXPERIMENTAL
Intervention: Imagery-based occupation
Number of subjects: 15
Study 1621796 — intervention group
Group type: COMPARATOR
Intervention: Rote exercise
Number of subjects: 15
Study 6230929 — intervention group
Group type: EXPERIMENTAL
Intervention: Chlorozotocin
Number of subjects: 122
Study 6230929 — intervention group
Group type: EXPERIMENTAL
Intervention: Neocarzinostatin
Number of subjects: 122
Study 6230929 — intervention group
Group type: EXPERIMENTAL
Intervention: MeCCNU
Number of subjects: 122
Study 29656823 — intervention group
Group type: EXPERIMENTAL
Intervention: Association Splitting (AS)
Number of subjects: 109
Study 29656823 — intervention group
Group type: COMPARATOR
Intervention: Cognitive Remediation (CR)
Number of subjects: 109
Study 27072798 — intervention group
Group type: EXPERIMENTAL
Intervention: Retro walking
Number of subjects: 69
Study 27072798 — intervention group
Group type: EXPERIMENTAL
Intervention: Forward walking
Number of subjects: 69
Study 27072798 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 69
Study 26277872 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexmedetomidine (loading dose of 1.0 μg/kg infused over 10 minutes, maintenance dose of 0.4 μg/kg per hour for 6 hours)
Number of subjects: 30
Study 26277872 — intervention group
Group type: COMPARATOR
Intervention: Normoalbuminemia (control group)
Number of subjects: 30
Study 23912692 — intervention group
Group type: COMPARATOR
Intervention: Gemcitabine alone (1,000 mg m(‐2))
Number of subjects: 46
Study 23912692 — intervention group
Group type: EXPERIMENTAL
Intervention: Gemcitabine plus cisplatin (G + C) (1,000 mg m(‐2) gemcitabine and 25 mg m(‐2) cisplatin)
Number of subjects: 46
Study 20206795 — intervention group
Group type: COMPARATOR
Intervention: Ticlopidine 250 mg alone
Number of subjects: 24
Study 20206795 — intervention group
Group type: EXPERIMENTAL
Intervention: Ticlopidine 250 mg with Ginkgo biloba extract 80 mg
Number of subjects: 24
Study 19115636 — intervention group
Group type: EXPERIMENTAL
Intervention: 20% protein‐free calf blood extract eye drops
Number of subjects: 240
Study 19115636 — intervention group
Group type: COMPARATOR
Intervention: 5000 IU/ml recombinant human epidermal growth factor (rhEGF) eye drops
Number of subjects: 240
Study 16570352 — intervention group
Group type: EXPERIMENTAL
Intervention: Sumatriptan
Number of subjects: 22
Study 16570352 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 22
Study 14740127 — intervention group
Group type: EXPERIMENTAL
Intervention: Graduated compression stockings (GCS) alone
Number of subjects: 39
Study 14740127 — intervention group
Group type: EXPERIMENTAL
Intervention: Graduated compression stockings (GCS) in combination with heparin
Number of subjects: 39
Study 14740127 — intervention group
Group type: COMPARATOR
Intervention: Graduated compression stockings (GCS)
Number of subjects: 39
Study 14740127 — intervention group
Group type: COMPARATOR
Intervention: Nontreatment or other antithrombotic methods
Number of subjects: 39
Study 11369627 — intervention group
Group type: EXPERIMENTAL
Intervention: Filgrastim-mobilized blood stem cell transplantation
Number of subjects: 115
Study 11369627 — intervention group
Group type: COMPARATOR
Intervention: Allogeneic marrow transplantation
Number of subjects: 115
Study 9408714 — intervention group
Group type: EXPERIMENTAL
Intervention: Active community-level intervention
Number of subjects: 22
Study 9408714 — intervention group
Group type: COMPARATOR
Intervention: Comparison
Number of subjects: 22
Study 7708953 — intervention group
Group type: EXPERIMENTAL
Intervention: Radiotherapy for early breast cancer
Number of subjects: 559
Study 7708953 — intervention group
Group type: EXPERIMENTAL
Intervention: Radiation dose distributions assessment in a separate group of 37 women
Number of subjects: 559
Study 3371023 — intervention group
Group type: EXPERIMENTAL
Intervention: 1.5 mg/kg iv every 6 h
Number of subjects: 40
Study 3371023 — intervention group
Group type: COMPARATOR
Intervention: 0.75 mg/kg iv every 6 h
Number of subjects: 40
Study 3371023 — intervention group
Group type: COMPARATOR
Intervention: 2 mg/kg by NG tube every 12 h
Number of subjects: 40
Study 3371023 — intervention group
Group type: COMPARATOR
Intervention: 4 mg/kg by NG tube every 12 h
Number of subjects: 40
Study 31941546 — intervention group
Group type: EXPERIMENTAL
Intervention: 7 days of antibiotic treatment
Number of subjects: 134
Study 31941546 — intervention group
Group type: COMPARATOR
Intervention: 14 days of antibiotic treatment
Number of subjects: 134
Study 30063766 — intervention group
Group type: COMPARATOR
Intervention: Leicester MII protocol in controls
Number of subjects: 56
Study 30063766 — intervention group
Group type: EXPERIMENTAL
Intervention: Leicester MII protocol in fever patients
Number of subjects: 56
Study 30063766 — intervention group
Group type: EXPERIMENTAL
Intervention: Leicester MII protocol in sepsis patients
Number of subjects: 56